Epilepsy is one of the most prevalent neurological diseases, affecting almost 70 million people globally and causing a significant burden to patients, their families, and healthcare systems (O'Donohoe et al., 2020). Neurodevelopmental delay during childhood, socioeconomic issues in adulthood, and comorbidities across age groups worsen the burden of seizures (Kanner, 2009; Ruggiero et al., 2012; Laxer et al., 2014; Chatterjee et al., 2020; Kobow et al., 2020; Oliveira et al., 2022). Psychiatric comorbidities affect persons with epilepsy regardless of seizure control. For instance, a Canadian-based study showed a 35% lifetime prevalence of mental health in persons with epilepsy compared to 20.7% in the average population (Tellez-Zenteno et al., 2007).
This Research Topic gathers experimental and clinical articles devoted to the elusive relationship between epilepsies and psychiatric disorders, ranging from molecular biology to treatment options. It is no surprise that most articles address research on mesial temporal lobe epilepsy (TLE). Psychiatric disorders, namely depression, are more likely to occur in mesial TLE than in neocortical TLE or extratemporal epilepsies (Dalmagro et al., 2012). This strong link between mesial TLE and psychiatric comorbidities is seen as an epiphenomenon since limbic structural abnormalities that characterize mesial TLE may play a vital role in mood disorders (Kandratavicius et al., 2012b,c; Valente and Busatto Filho, 2013).
Michaelis et al. described the frequency of mood disorders, anxiety disorders, and functional seizures at a tertiary health care center. Their study reinforced the need for psychiatric screening in persons with epilepsy. Diagnosing these comorbidities with higher precision is crucial for the proper management of patients, corroborating previous studies (Kanner, 2016; Ribot et al., 2017; Michaelis et al., 2018; Asadi-Pooya et al., 2019; Baroni et al., 2021; Jungilligens et al., 2021).
Kanner addressed the prevalence, risk factors, and shared mechanisms of suicidality in persons with epilepsy. The author reviewed how different psychiatric comorbidities, seizures, and genetic and social factors impact suicidality. Kanner also emphasizes the relevance of screening in preventing suicide in these patients. As other studies have shown several risk factors for suicidality in persons with epilepsy (Jones et al., 2003; Mula et al., 2013; Pugh et al., 2013), this review by Kanner could be of broad interest. Kanner and Michaelis et al. clinical papers emphasize the urgent need for integrated mental health care to improve quality of life and decrease mortality in persons with epilepsy.
Bandeira et al. described changes in the methylation status of BDNF and SLC6A4 promoters in peripheral blood samples from persons with TLE with mood and anxiety disorders. The authors also analyzed other potential factors associated with TLE comorbidities, including genes widely explored in psychiatry and epileptology (Hu and Russek, 2008; Esmail et al., 2015), and could shed light on specific differences between types of psychiatric comorbidity. Methylation studies are advancing our comprehension of psychiatric and neurologic diseases in general (Bakusic et al., 2017; Capper et al., 2018; Barbu et al., 2022; Jabari et al., 2022).
Visoná de Figueiredo et al. investigated associations between different types of hippocampal sclerosis (as defined by the International League Against Epilepsy in Blümcke et al., 2013) and depression. They also studied whether neuron density differs between TLE patients with and without depression. Their study follows up on previous reports on histopathological differences between patients with and without psychiatric comorbidities in general (Kandratavicius et al., 2012a, 2014, 2015) and between types of hippocampal sclerosis and epilepsy-related factors (Coras et al., 2014; Thom, 2014; Rodrigues et al., 2015; Dombroski et al., 2020).
Godoy et al. reviewed studies on parvalbumin-positive interneuron populations in patients and animal models of epilepsy. They also described the GABAergic contribution to psychiatric comorbidities and how treatments could impact the function of these interneurons. Godoy et al. contributed a timely review, as the role of these interneurons in epilepsy and psychiatric diseases are increasingly gaining recognition (Jiang et al., 2016; Taylor et al., 2019; Spijker et al., 2020).
Bragatti reviewed the history and possible mechanisms of forced normalization. This phenomenon, where psychotic-like behavior emerges in some TLE patients after successful seizure control, is still not fully understood. Bragatti reinforced the controversies around forced normalization and discussed theories to explain the mismatch between animal models and human data. As psychosis adds a vital burden to persons with epilepsy (Bragatti et al., 2010; de Toffol et al., 2018), a better understanding of forced normalization vs. epilepsy-unrelated psychosis may improve patient care.
Mota et al. investigated whether a self-applied transcranial direct-current stimulation (tDCS) over the dorsolateral prefrontal cortex was better than a placebo at treating depression and anxiety in TLE patients. Their results are interesting and reinforce the need for further investigation, especially when compared to studies showing the efficacy of tDCS in depressive patients without epilepsy (Zhang et al., 2021). Non-pharmacological treatments like tDCS are promising at reducing both the adverse effects and the number of medications, two critical factors behind the low adherence to pharmacological treatment in TLE (Laville et al., 2018; Steinert and Fröscher, 2018).
In summary, this Research Topic is of interest to epileptologists, psychiatrists, and laboratory researchers. Although informed health care professionals recognize the psychiatric aspects of epilepsy, managing the affected patients is still challenging (Gandy et al., 2021), which continues to justify basic and clinical research.
Funding
We thank Fundação de Amparo á Pesquisa do Estado de São Paulo (FAPESP, grants #16/17882-4 and #18/02303-4) and Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico (CNPq, grants #422911/2021-6 and #307817/2019-9) for the financial support.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
All authors listed have made an equally substantial, direct, and intellectual contribution to the work and approved it for publication.
Acknowledgments
We thank Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, grant #16/17882-4) and Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico (CNPq, grant #422911/2021-6) for the financial support.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
Asadi-Pooya A. A. Valente K. Restrepo A. D. D'Alessio L. Homayoun M. Bahrami Z. et al . (2019). Adult-onset psychogenic nonepileptic seizures: a multicenter international study. Epilepsy Behav.98, 36–39. 10.1016/j.yebeh.2019.06.013
2
Bakusic J. Schaufeli W. Claes S. Godderis L. (2017). Stress, burnout and depression: a systematic review on DNA methylation mechanisms. J. Psychosom. Res.92, 34–44. 10.1016/j.jpsychores.2016.11.005
3
Barbu M. C. Amador C. Kwong A. S. F. Shen X. Adams M. J. Howard D. M. et al . (2022). Complex trait methylation scores in the prediction of major depressive disorder. EBioMedicine79, 104000. 10.1016/j.ebiom.2022.104000
4
Baroni G. Martins W. A. Rodrigues J. C. Piccinini V. Marin C. de Lara Machado W. et al . (2021). A novel scale for suspicion of psychogenic nonepileptic seizures: development and accuracy. Seizure89, 65–72. 10.1016/j.seizure.2021.04.025
5
Blümcke I. Thom M. Aronica E. Armstrong D. D. Bartolomei F. Bernasconi A. et al . (2013). International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia54, 1315–1329. 10.1111/epi.12220
6
Bragatti J. A. Torres C. M. Londero R. G. Assmann J. B. Fontana V. Martin K. C. et al . (2010). Prevalence of psychiatric comorbidities in temporal lobe epilepsy: the value of structured psychiatric interviews. Epileptic Disord.12, 283–291. 10.1684/epd.2010.0345
7
Capper D. Jones D. T. W. Sill M. Hovestadt V. Schrimpf D. Sturm D. et al . (2018). DNA methylation-based classification of central nervous system tumours. Nature555, 469–474. 10.1038/nature26000
8
Chatterjee A. Nair R. Gandeti R. Puppala G. K. Chandran V. Gorthi S. P. et al . (2020). Socioeconomic consequences of drug-resistant epilepsy in an adult cohort from southern India. Epilepsy Behav.110, 107173. 10.1016/j.yebeh.2020.107173
9
Coras R. Pauli E. Li J. Schwarz M. Rössler K. Buchfelder M. et al . (2014). Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy. Brain137, 1945–1957. 10.1093/brain/awu100
10
Dalmagro C. L. Velasco T. R. Bianchin M. M. Martins A. P. P. Guarnieri R. Cescato M. P. et al . (2012). Psychiatric comorbidity in refractory focal epilepsy: a study of 490 patients. Epilepsy Behav.25, 593–597. 10.1016/j.yebeh.2012.09.026
11
de Toffol B. Trimble M. Hesdorffer D. C. Taylor L. Sachdev P. Clancy M. et al . (2018). Pharmacotherapy in patients with epilepsy and psychosis. Epilepsy Behav.88, 54–60. 10.1016/j.yebeh.2018.09.001
12
Dombroski T. C. D. Peixoto-Santos J. E. Maciel K. Baqui M. M. A. Velasco T. R. Sakamoto A. C. et al . (2020). Drebrin expression patterns in patients with refractory temporal lobe epilepsy and hippocampal sclerosis. Epilepsia61, 1581–1594. 10.1111/epi.16595
13
Esmail E. H. Labib D. M. Rabie W. A. (2015). Association of serotonin transporter gene. (5HTT). polymorphism and juvenile myoclonic epilepsy: a case-control study. Acta Neurol. Belg.115, 247–251. 10.1007/s13760-014-0400-1
14
Gandy M. Modi A. C. Wagner J. L. LaFrance W. C. Reuber M. Tang V. et al . (2021). Managing depression and anxiety in people with epilepsy: a survey of epilepsy health professionals by the ILAE Psychology Task Force. Epilepsia Open6, 127–139. 10.1002/epi4.12455
15
Hu Y. Russek S. J. (2008). BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation. J. Neurochem.105, 1–17. 10.1111/j.1471-4159.2008.05237.x
16
Jabari S. Kobow K. Pieper T. Hartlieb T. Kudernatsch M. Polster T. et al . (2022). DNA methylation-based classification of malformations of cortical development in the human brain. Acta Neuropathol.143, 93–104. 10.1007/s00401-021-02386-0
17
Jiang X. Lachance M. Rossignol E. (2016). Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy. Prog. Brain Res.226, 81–126. 10.1016/bs.pbr.2016.04.012
18
Jones J. E. Hermann B. P. Barry J. J. Gilliam F. G. Kanner A. M. Meador K. J. (2003). Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav.4(Suppl. 3), S31–S38. 10.1016/j.yebeh.2003.08.019
19
Jungilligens J. Michaelis R. Popkirov S. (2021). Misdiagnosis of prolonged psychogenic non-epileptic seizures as status epilepticus: epidemiology and associated risks. J. Neurol. Neurosurg. Psychiatry92, 1341–1345. 10.1136/jnnp-2021-326443
20
Kandratavicius L. Hallak J. E. Carlotti C. G. Assirati J. A. Leite J. P. (2014). Neurotrophin receptors expression in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with seizure type and surgical outcome. Acta Neuropathol. Commun.2, 81. 10.1186/s40478-014-0081-2
21
Kandratavicius L. Hallak J. E. Young L. T. Assirati J. A. Carlotti C. G. Leite J. P. (2012a). Differential aberrant sprouting in temporal lobe epilepsy with psychiatric co-morbidities. Psychiatry Res.195, 144–150. 10.1016/j.psychres.2011.06.005
22
Kandratavicius L. Lopes-Aguiar C. Bueno-Júnior L. S. Romcy-Pereira R. N. Hallak J. E. C. Leite J. P. (2012b). Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits. Rev. Bras. Psiquiatr.34, 454–466. 10.1016/j.rbp.2012.04.007
23
Kandratavicius L. Peixoto-Santos J. E. Monteiro M. R. Scandiuzzi R. C. Carlotti C. G. Assirati J. A. et al . (2015). Mesial temporal lobe epilepsy with psychiatric comorbidities: a place for differential neuroinflammatory interplay. J. Neuroinflamm.12, 38. 10.1186/s12974-015-0266-z
24
Kandratavicius L. Ruggiero R. N. Hallak J. E. Garcia-Cairasco N. Leite J. P. (2012c). Pathophysiology of mood disorders in temporal lobe epilepsy. Rev. Bras. Psiquiatr.34(Suppl. 2), S233–S245. 10.1016/j.rbp.2012.08.003
25
Kanner A. M. (2009). Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav.15, 83–87. 10.1016/j.yebeh.2009.02.034
26
Kanner A. M. (2016). Management of psychiatric and neurological comorbidities in epilepsy. Nat. Rev. Neurol.12, 106–116. 10.1038/nrneurol.2015.243
27
Kobow K. Jabari S. Pieper T. Kudernatsch M. Polster T. Woermann F. G. et al . (2020). Mosaic trisomy of chromosome 1q in human brain tissue associates with unilateral polymicrogyria, very early-onset focal epilepsy, and severe developmental delay. Acta Neuropathol.140, 881–891. 10.1007/s00401-020-02228-5
28
Laville F. Montana M. Roux N. Rathelot P. Giorgi R. Vanelle P. (2018). Factors limiting adherence to antiepileptic treatment: a French online patient survey. J. Clin. Pharm. Ther.43, 73–79. 10.1111/jcpt.12615
29
Laxer K. D. Trinka E. Hirsch L. J. Cendes F. Langfitt J. Delanty N. et al . (2014). The consequences of refractory epilepsy and its treatment. Epilepsy Behav.37, 59–70. 10.1016/j.yebeh.2014.05.031
30
Michaelis R. Schöller H. Höller Y. Kalss G. Kirschner M. Schmid E. et al . (2018). Integrating the systematic assessment of psychological states in the epilepsy monitoring unit: concept and compliance. Epilepsy Behav.88, 5–14. 10.1016/j.yebeh.2018.08.029
31
Mula M. Kanner A. M. Schmitz B. Schachter S. (2013). Antiepileptic drugs and suicidality: an expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology. Epilepsia54, 199–203. 10.1111/j.1528-1167.2012.03688.x
32
O'Donohoe T. J. Choudhury A. Callander E. (2020). Global macroeconomic burden of epilepsy and the role for neurosurgery: a modelling study based upon the 2016 Global Burden of Disease data. Eur. J. Neurol.27, 360–368. 10.1111/ene.14085
33
Oliveira M. C. Lima E. M. de Paiva M. L. N. Valente K. D. R. (2022). Factors associated with caregiver burden of adults with epilepsy in a middle-income country. Seizure98, 1–7. 10.1016/j.seizure.2022.03.015
34
Pugh M. J. V. Hesdorffer D. Wang C.-P. Amuan M. E. Tabares J. V. Finley E. P. et al . (2013). Temporal trends in new exposure to antiepileptic drug monotherapy and suicide-related behavior. Neurology81, 1900–1906. 10.1212/01.wnl.0000436614.51081.2e
35
Ribot R. Ouyang B. Kanner A. M. (2017). The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: is it worth investigating?Epilepsy Behav.70, 5–9. 10.1016/j.yebeh.2017.02.032
36
Rodrigues G. R. Kandratavicius L. Peixoto-Santos J. E. Monteiro M. R. Gargaro A. C. De Vasconcelos Leite Geraldi C. et al . (2015). Increased frequency of hippocampal sclerosis ILAE type 2 in patients with mesial temporal lobe epilepsy with normal episodic memory. Brain138, e359. 10.1093/brain/awu340
37
Ruggiero R. N. Lopes-Aguiar C. Leite J. P. (2012). Early life seizures and their long-term impacts on cognition: the role of synaptic plasticity dysfunctions as an underlying mechanism. J. Epilepsy Clin. Neurophysiol.18, 114–120. Available online at: http://files.bvs.br/upload/S/1676-2649/2012/v18n4/a4890.pdf
38
Spijker S. Koskinen M.-K. Riga D. (2020). Incubation of depression: ECM assembly and parvalbumin interneurons after stress. Neurosci. Biobehav. Rev.118, 65–79. 10.1016/j.neubiorev.2020.07.015
39
Steinert T. Fröscher W. (2018). Epileptic seizures under antidepressive drug treatment: systematic review. Pharmacopsychiatry51, 121–135. 10.1055/s-0043-117962
40
Taylor S. F. Grove T. B. Ellingrod V. L. Tso I. F. (2019). The Fragile brain: stress vulnerability, negative affect and GABAergic neurocircuits in psychosis. Schizophr. Bull.45, 1170–1183. 10.1093/schbul/sbz046
41
Tellez-Zenteno J. F. Patten S. B. Jetté N Williams J. Wiebe S. (2007). Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia48, 2336–2344. 10.1111/j.1528-1167.2007.01222.x
42
Thom M. (2014). Review: hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol. Appl. Neurobiol.40, 520–543. 10.1111/nan.12150
43
Valente K. D. R. Busatto Filho G. (2013). Depression and temporal lobe epilepsy represent an epiphenomenon sharing similar neural networks: clinical and brain structural evidences. Arq. Neuropsiquiatr.71, 183–190. 10.1590/S0004-282X2013000300011
44
Zhang R. Lam C. L. M. Peng X. Zhang D. Zhang C. Huang R. et al . (2021). Efficacy and acceptability of transcranial direct current stimulation for treating depression: a meta-analysis of randomized controlled trials. Neurosci. Biobehav. Rev.126, 481–490. 10.1016/j.neubiorev.2021.03.026
Summary
Keywords
epilepsy, depression, psychosis, suicidality, anxiety, pharmacoresistance
Citation
Ruggiero RN, Peixoto-Santos JE, Bueno-Junior LS, Valente KD and Leite JP (2022) Editorial: Psychiatric Comorbidities in the Epilepsies: Extensive Mechanisms and Broad Questions. Front. Integr. Neurosci. 16:951170. doi: 10.3389/fnint.2022.951170
Received
23 May 2022
Accepted
31 May 2022
Published
17 June 2022
Volume
16 - 2022
Edited and reviewed by
Elizabeth B. Torres, The State University of New Jersey, United States
Updates
Copyright
© 2022 Ruggiero, Peixoto-Santos, Bueno-Junior, Valente and Leite.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rafael Naime Ruggiero rafaruggiero@usp.br
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.